Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

653

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
COPD
Interventions
DRUG

SUN-101 50 mcg BID eFlow (CS) nebulizer

SUN-101 50 mcg twice daily (BID) eFlow Closed System (CS) nebulizer

DRUG

SUN-101 25 mcg BID eFlow (CS) nebulizer

SUN-101 25 mcg twice daily (BID) eFlow Closed System (CS) nebulizer

DRUG

Placebo BID eFlow Closed System (CS) nebulizer

Placebo twice daily (BID) eFlow Closed System (CS) nebulizer

Trial Locations (44)

14618

AAIR Research Center, Rochester

15243

Research Protocol Management Specialists, Pittsburgh

23225

Pulmonary Associates of Richmond, Inc., Richmond

24210

Pulmonary Research of Abingdon, LLC, Abingdon

27607

North Carolina Clinical Research, Raleigh

28207

American Health Research, Inc., Charlotte

28401

PMG Research of Wilmington, Wilmington

28602

Hickory Research Center, Hickory

29303

S. Carolina Pharmaceutical Research, Spartanburg

Spartanburg Medical Research, Spartanburg

29379

CU Pharmaceutical Research, Union

29615

Greenville Pharmaceutical Research, Inc, Greenville

Upstate Pharmaceutical Research, Greenville

29640

Palmetto Medical Research Associates, LLC, Easley

29707

Piedmont Research Partners, LLC, Old Point Station

31904

Columbus Regional Research Institute, Columbus

32132

Riverside Clinical Research, Edgewater

32405

Emerald Coast Research Associates, Panama City

32825

Florida Institute for Clinical Research, LLC, Orlando

33155

AppleMed Research, Inc., Miami

33186

Clinical Trials of Florida, LLC, Miami

33603

Clinical Research of West Florida, Inc, Tampa

33765

Clinical Research of West Florida, Inc., Clearwater

34711

Clermont Medical Research, Clermont

34741

Pulmonary Disease Specialists, PA, d/b/a PDS Research, Kissimmee

36207

Pinnacle Research Group, LLC, Anniston

41017

Abraham Reasearch, PLLC, Fort Mitchell

43213

Columbus Clinical Research, Inc, Columbus

43235

Optimed Research, LTD, Columbus

48152

Pulmonary Research Institute of Southeast Michigan, Livonia

55125

Minnesota Lung Center, Woodbury

55435

Minnesota Lung Center, Edina

63301

Midwest Chest Consultants, P.C., Saint Charles

76104

Texas Pulmonary and Critical Care Consultants, PA, Fort Worth

77099

Pioneer Research Solutions, Inc., Houston

78130

Central Texas Health Research, New Braunfels

78229

Sylvana Research Associates, San Antonio

80033

Western States Clinical Research, Inc., Wheat Ridge

85006

Pulmonary Associates, PA, Phoenix

85283

Clinical Research Consortium - Arizona, Tempe

85710

Desert Sun Clinical Research, LLC, Tucson

89119

Clinical Research Consortium, Las Vegas

97504

Clinical Research Institute of Southern Oregon, PC, Medford

02914

Safe Harbor Clinical Research, East Providence

All Listed Sponsors
lead

Sunovion Respiratory Development Inc.

INDUSTRY

NCT02347761 - Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD | Biotech Hunter | Biotech Hunter